Philips initiated a voluntary recall for some of its sleep apnea machines and ventilators. The American multinational conglomerate company cited concerns for a foam component that may get detached or degrade and become toxic when inhaled by the user.
It was said that if such a thing happens, there is a possibility it could cause health issues including the development of cancer due to toxic and carcinogenic effects. To prevent this and protect the users, Philips issued a recall notification on Monday, June 14.
The affected devices and Philips’ announcement
As per Fox Business, the Philips recall will affect three to four million units of certain machine models that feature Bi-Level Positive Airway Pressure (Bi-Level PAP), Continuous Positive Airway Pressure (CPAC) and the mechanical ventilator machines. It was revealed that the company already issued the first warning over the issue in April.
Philips announced its voluntary recall notification after consulting with regulatory agencies. The company said that with the recalled products, the company will immediately take corrective actions that include the distribution of updated instructions for the repair and replacement of the affected items. As of this time, Philips is continuously monitoring reports of safety issues and so far, it has not received any reports of death due to the product issues.
It was added that due to potential risks of exposure, users may experience headaches, respiratory issues, irritation, inflammation and possible toxic or carcinogenic effects. But fortunately, there is no report of these effects yet related to chemical emissions.
“We deeply regret any concern and inconvenience that patients using the affected devices will experience because of the proactive measures we are announcing today to ensure patient safety,” Philips CEO, Frans van Houten, said in a press release. “In consultation with the relevant regulatory agencies and in close collaboration with our customers and partners, we are working hard towards a resolution. Patient safety is at the heart of everything we do at Philips.”
How Philips will solve the issue
Reuters reported that Philips is now working with the health authorities and regulators for the safety of the consumers. It is looking for a way for the safe replacement of the foam that may potentially become toxic and cause cancer.
It was added that Philips is not conducting tests and it needs to get good results so it can pass the regulatory requirements. The company will also be replacing the products that cannot be repaired or updated.


Singapore Budget 2026 Set for Fiscal Prudence as Growth Remains Resilient
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target
U.S. Stock Futures Slide as Tech Rout Deepens on Amazon Capex Shock
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
South Korea’s Weak Won Struggles as Retail Investors Pour Money Into U.S. Stocks
Global Markets Slide as AI, Crypto, and Precious Metals Face Heightened Volatility
Fed Governor Lisa Cook Warns Inflation Risks Remain as Rates Stay Steady
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Gold and Silver Prices Rebound After Volatile Week Triggered by Fed Nomination
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns
South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns
Asian Stocks Slip as Tech Rout Deepens, Japan Steadies Ahead of Election
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 



